Fensolvi

(leuprolide acetate)

Fensolvi 45 MG in 0.375 ML (6 month) Prefilled Syringe

NO BLACK BOX WARNING

Dosage & administration

* Must be administered by a healthcare provider.
* The dose of FENSOLVI is 45 mg administered by subcutaneous injection once every six months.
* Monitor response to FENSOLVI with a GnRH agonist stimulation test, basal serum luteinizing hormone (LH) levels or serum concentration of sex steroid levels at 1 to 2 months following initiation of therapy and as needed to confirm adequate suppression of pituitary gonadotropins, sex steroids, and progression of secondary sexual characteristics.
* Measure height every 3 to 6 months and monitor bone age periodically.
* See Full Prescribing Information for reconstitution and administration instructions.

drug label

Fensolvi prescribing information

Report Adverse Event

prior authorization

Fensolvi prior authorization resources

PDFComplete Letter of Medical Necessity

Learn More

Benefits investigation

PDFFelsolvi Total Solutions Enrollment Form

Learn More

financial assistance

Fensolvi financial assistance options

Co-pay savings program

commercial only

PDFFelsolvi Total Solutions Enrollment Form

PDFEnroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

PDFFelsolvi Total Solutions Enrollment Form

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Fensolvi patient education

Getting started on Fensolvi

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link